Mateusz G.
- Country
- Poland
- Department
- Pratia Chojnice
Research Overview
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety of Cannabis Sativa Flower Aerosol via Syqe Inhaler in Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
- A multicenter randomized, double-blind, placebo-controlled Phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP) / NEPTUNE-17.
Data & Insights
Has run more than one trial at 9 of 214 partner sites.
Specializations
Neuropathic Pain Management
This investigator specializes in treating diabetic peripheral neuropathic pain (DPNP), focusing on innovative therapeutic approaches for managing chronic pain conditions associated with diabetes.
- Diabetic neuropathy interventions
- Pain management strategies
- Peripheral nerve disorders
The research encompasses both traditional and emerging treatment modalities for neuropathic pain conditions.
Novel Therapeutics
The investigator explores alternative treatment approaches including both pharmaceutical compounds and medical cannabis applications for chronic pain management.
- Innovative pain medications
- Medical cannabis research
- Drug delivery systems
Their work includes evaluation of various administration methods including aerosol delivery systems for pain management.
Diabetes Complications
The investigator focuses on addressing diabetes-related complications, particularly those affecting the peripheral nervous system and resulting in chronic pain conditions.
- Diabetic complications
- Neurological disorders
- Pain assessment methods
Their research aims to better understand and treat the complex relationship between diabetes and neuropathic pain.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.